Tweet
Catalyst Capital Advisors LLC cut its holdings in shares of Healthequity Inc (NASDAQ:HQY) by 14.8% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 7,917 shares of the company's stock after selling 1,377 shares during the period. Catalyst Capital Advisors LLC's holdings in Healthequity were worth $594,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Global X Management Co. LLC increased its holdings in Healthequity by 89.8% in the first quarter. Global X Management Co. LLC now owns 69,481 shares of the company's stock worth $4,206,000 after buying an additional 32,880 shares during the last quarter. Rhumbline Advisers increased its holdings in Healthequity by 2.7% in the first quarter. Rhumbline Advisers now owns 118,926 shares of the company's stock worth $7,200,000 after buying an additional 3,097 shares during the last quarter. Morse Asset Management Inc increased its holdings in Healthequity by 59.6% in the first quarter. Morse Asset Management Inc now owns 37,595 shares of the company's stock worth $2,276,000 after buying an additional 14,040 shares during the last quarter. Migdal Insurance & Financial Holdings Ltd. acquired a new position in Healthequity in the first quarter worth approximately $1,451,000. Finally, Comerica Bank increased its holdings in Healthequity by 2.5% in the first quarter. Comerica Bank now owns 55,163 shares of the company's stock worth $3,651,000 after buying an additional 1,361 shares during the last quarter. Institutional investors own 95.38% of the company's stock. Get Healthequity alerts:
In other Healthequity news, VP Darcy G. Mott sold 9,500 shares of the company's stock in a transaction that occurred on Monday, May 21st. The stock was sold at an average price of $73.93, for a total transaction of $702,335.00. Following the completion of the sale, the vice president now owns 111,500 shares of the company's stock, valued at $8,243,195. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website . Also, Director Frank Medici sold 6,904 shares of the company's stock in a transaction that occurred on Friday, July 13th. The stock was sold at an average price of $80.40, for a total value of $555,081.60. Following the sale, the director now directly owns 17,649 shares of the company's stock, valued at approximately $1,418,979.60. The disclosure for this sale can be found here . Insiders have sold 57,100 shares of company stock valued at $4,457,965 in the last ninety days. Company insiders own 4.00% of the company's stock.
Shares of Healthequity stock opened at $86.86 on Friday. The company has a market cap of $5.12 billion, a price-to-earnings ratio of 160.85, a P/E/G ratio of 3.43 and a beta of 1.37. Healthequity Inc has a 12-month low of $40.21 and a 12-month high of $87.79.
Healthequity (NASDAQ:HQY) last announced its earnings results on Monday, June 4th. The company reported $0.31 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.22 by $0.09. The firm had revenue of $69.90 million during the quarter, compared to analysts' expectations of $68.81 million. Healthequity had a return on equity of 13.47% and a net margin of 22.91%. The company's revenue was up 26.2% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.23 earnings per share. equities analysts forecast that Healthequity Inc will post 0.72 EPS for the current fiscal year.
HQY has been the topic of a number of research reports. KeyCorp increased their price objective on Healthequity from $82.00 to $90.00 and gave the stock a "buy" rating in a report on Thursday, July 19th. Cantor Fitzgerald restated a "hold" rating and issued a $68.00 price objective (up previously from $65.00) on shares of Healthequity in a report on Monday, June 4th. JPMorgan Chase & Co. initiated coverage on Healthequity in a report on Tuesday, April 24th. They issued an "overweight" rating and a $69.00 price objective on the stock. Zacks Investment Research upgraded Healthequity from a "sell" rating to a "hold" rating in a report on Friday, July 20th. Finally, Bank of America initiated coverage on Healthequity in a report on Wednesday, May 23rd. They issued a "buy" rating and a $83.00 price objective on the stock. Three investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have issued a strong buy rating to the stock. The company presently has an average rating of "Buy" and a consensus target price of $77.73.
Healthequity Company Profile
HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Featured Story: Outstanding Shares Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter 